Results

Total Results: 1,430 records

Showing results for "continued".

1. Template for Draft Reports (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-pci-bypass_appendixes.pdf
   October 06, 2006 - /ti,ab A-1 Appendix A: Search Strategies (continued) s11 percutaneous coronary intervention … A-5 Appendix A: Search Strategies (continued) A-6 13. … C-2 Appendix C: Additional Analyses and Evidence Tables (continued) Appendix Table 2. … C-4 Appendix C: Additional Analyses and Evidence Tables (continued) Appendix Table 3. … Appendix C: Additional Analyses and Evidence Tables (continued) Appendix Table 10.

2. Effectiveness of Noninvasive Diagnostic Tests for Breast Abnormalities Appendices (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-abnormalities-tests_appendixes.pdf
   May 23, 2005 - Evidence Tables (continued) Table 29. … Evidence Tables (continued) Table 30. … Evidence Tables (continued) Table 31. … Evidence Tables (continued) Table 33. … Evidence Tables (continued) Table 34.

3. Draft Comparative Effectiveness Review Appendicies (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_appendixes.pdf
   April 01, 2005 - Excluded Studies (continued) Baumgartner I, Triller J, Mahler F. … Excluded Studies (continued) Ramsay LE, Waller PC. … Detailed Summary Table (continued) Table. … Detailed Summary Table (continued) Table. … Detailed Summary Table (continued) Table.

4. CER 218 Evidence Summary: Long-Term Drug Therapy and Drug Holidays for Osteoporosis Fracture Prevention: A Systematic Review (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-218-osteoporosis-fracture-prevention-evidence-summary.pdf
   April 01, 2019 - Evidence on efficacy of long-term (>3 years) osteoporosis drug treatment (continued) 6 Comparison … Evidence on efficacy of long-term (>3 years) osteoporosis drug treatment (continued) Harms Due to … Evidence on harms of long-term (>3 years) osteoporosis drug treatment (continued) 10 Comparison … Evidence on harms of long-term (>3 years) osteoporosis drug treatment (continued) Abbreviations: AFF … discontinuation (Continued BP 3.5 yr [mean] [persistent group] or 4.1 yr [mean] [nonpersistent

5. Peripheral-Artery-Disease-Treatment Executive (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/peripheral-artery-disease-treatment_executive.pdf
   May 01, 2013 - aspirin in adults with PAD at 2 years (continued) Symptomatic– asymptomatic population (CHARISMA … ) (continued) Safety concerns SOE=Insufficient 1 RCT, 3,096 patients Inconclusive evidence due to … aspirin in adults with PAD at 2 years (continued) IC–CLI population (CASPAR, MIRROR, Cassar) (continued … usual care (continued) Primary patency Secondary patency SOE=Insufficient 1 observational study, … exercise training (continued) ICD or PFWD SOE=Low 5 RCTs, 448 patients ES: 0.10 (-0.38 to 0.58)

6. CER 218 Disposition of Comments: Long-Term Drug Therapy and Drug Holidays for Osteoporosis Fracture Prevention (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-218-osteoporosis-disposition-comments.pdf
   April 23, 2019 - denosumab on bone density and turnover in postmenopausal w omen w ith low bone mass after long-term continued … However, the effect of continued versus discontinued alendronate on risk of incident clinical vertebral … There are several statements about the benefits and risks of continued treatment versus interruption … of treatment after 3 to 5 years that state categorically that continued treatment does not lower risk … However, the effect of continued versus discontinued alendronate on risk of incident clinical vertebral

7. Layout 1 (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_executive.pdf
   March 01, 2011 - (continued) Cardiovascular and Low A comparison of the risk of cardiovascular morbidity between metformin … (continued) Hypoglycemia High The risk of hypoglycemia with metformin plus sulfonylurea exceeds (continued … (continued) Gastrointestinal Moderate Metformin was associated with twice as many GI adverse event rates … (continued) Moderate Metformin monotherapy was associated with more frequent GI adverse events than … (continued) Fractures High The risk of fracture was higher for thiazolidinediones than for metformin

8. Treatment of Depression in Children and Adolescents: A Systematic Review - Evidence Summary (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/Evidence%20Summary_0_0.pdf
   April 01, 2020 - Two RCTs compared relapse prevention CBT plus continued antidepressant medication with continued medication … Strength of Evidence for outcomes of pharmacotherapy versus placebo (continued) 16 Comparison ( … Strength of Evidence for outcomes of pharmacotherapy versus placebo (continued) 17 Table C. … Strength of Evidence for outcomes of pharmacotherapy versus placebo (continued) a For CGAS, the 0.5 … pharmacotherapy 8-28 weeks (continued) Remission from MDD Risk difference (combination vs.

9. Layout 1 (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/sleep-apnea_executive.pdf
   July 01, 2011 - PSG (continued) (continued) • Conclusion: The strength of evidence is moderate that Type III and IV … of Key Question Evidence Summary/Conclusions/Comments Key Question 1: Low (continued) • A single … The other clinical prediction rules had (continued) variable accuracy for predicting OSA (AHI ≥5, 10 … of Key Question Evidence Summary/Conclusions/Comments Key Question 5: Moderate (continued) • All … ) (continued) bariatric surgery, nasal dilator strips, acupuncture, and auricular plaster.

10. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/gerd-2005_executive.pdf
    January 01, 2005 - Data on comparative endoscopic treatments with continued (or intensified) use of PPIs are needed to better … Continued 5 Continued Table A. … Summary of Comparative Data on Treatments of GERD (continued) Key Question 1: Quality of comparisons … Acceptable Open fundoplication vs. omeprazole in patients with GERD but surgical (continued) without … Summary of Comparative Data on Treatments of GERD (continued) Key Question 3: Quality of adverse events

11. Disposition of Comments_Systematic Review: Implementing Recommended Mental Health and Substance Use Screening and Counseling Interventions in Primary Care Settings for in Children and Adolescents (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/behavioral-health-screening-disposition-comments.pdf
    April 09, 2025 - April 9, 2025 25 Commenter Section Comment EPC Response Public Reviewer: Richard Lawhern (continued … April 9, 2025 26 Commenter Section Comment EPC Response Public Reviewer: Richard Lawhern (continued … ) Results (continued) • While this is not a study about implementation of mental health screening … ) Results (continued) Another recent, relevant epidemiological study by Ruch et al. (2024) may … ) Results (continued) • Lois, B.

12. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/gerd_executive.pdf
    September 01, 2011 - Strength of evidence on comparative effectiveness of treatments for GERD (continued) Strength of Key … that maintenance-treatment (continued) patients taking lansoprazole 15 mg are likely to stay longer … Strength of evidence on comparative effectiveness of treatments for GERD (continued) Strength of Key … Medical treatment comparisons (continued): Comparisons between once-daily and - One RCT reported that … Surgical treatment comparisons (continued): Laparoscopic vs. open fundoplication Moderate • Two RCTs

13. Rheumatoid-Arthritis-Medicine Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-medicine_executive.pdf
    April 01, 2012 - Summary of findings with strength of evidence (continued) Key Comparisons Efficacy Strength of Evidence … Oral DMARD (continued) Oral DMARD plus prednisone vs. oral DMARD Mixed results for disease activity … Summary of findings with strength of evidence (continued) Key Comparisons Efficacy Strength of Evidence … Biologic DMARDs (continued) Biologic vs. biologic (Mixed treatment comparisons) (continued) Greater … Harms Strength of Evidence Biologic DMARD Combinations (continued) Biologic DMARDs plus MTX vs.

14. Migraine Protocol-Appendix 20111103 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine_protocol-appendix_20111103.pdf
    November 03, 2011 - Literature search strings (continued) Source: www.effectivehealthcare.ahrq.gov Published Online: … Literature search strings (continued) Source: www.effectivehealthcare.ahrq.gov Published Online: … Literature search strings (continued) Source: www.effectivehealthcare.ahrq.gov Published Online: … Literature search strings (continued) Source: www.effectivehealthcare.ahrq.gov Published Online: … Literature search strings (continued) Source: www.effectivehealthcare.ahrq.gov Published Online:

15. Effectiveness and Safety of Bronchial Thermoplasty in Management of Asthma: Evidence Summary (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-summary-cer-202-bronchial-thermoplasty-asthma.pdf
    December 01, 2017 - Analytic framework for bronchial thermoplasty in asthma Adults with asthma Bronchial thermoplasty and continued … medical management Continued medical management Or Sham bronchoscopy and continued medical … management), and one multicenter RCT comparing BT to a sham bronchoscopy intervention with standard care continued

16. Disposition of Comments Report for Imaging Techniques for Treatment Evaluation for Metastatic Breast Cancer (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-imaging_disposition-comments.pdf
    October 01, 2014 - Findings (continued) Page 13 line 48: Not entirely correct. … Online: October 1, 2014 4 Commentator & Affiliation Section Comment Response Findings (continued … Findings (continued) Page 15 line 14-15: description of PET is simplistic. … Findings (continued) What are the implications of access and usage trends given evidence from studies … General Comments (continued) A more appropriate endpoint for diagnostic imaging would be similar

17. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_executive.pdf
    October 01, 2006 - Summary of Comparative Data in Treatments of Renal Artery Stenosis (continued) Key Questions Strength … cohort studies, larger reductions in blood pressure were (continued) found among medical treatment … Summary of Comparative Data in Treatments of Renal Artery Stenosis (continued) Key Questions Strength … of evidence Summary/conclusion/comments Key Question 2: Baseline predictors of outcomes (continued) … of evidence Summary/conclusion/comments Key Question 2: Baseline predictors of outcomes (continued)

18. Microsoft Word - finapps.doc (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_appendixes-2007.pdf
    January 01, 2007 - Direct comparisons of angioplasty or surgery and medical treatment for renal artery stenosis (continued … ~79% 37 0 29% 71% 52% 48% Retro Multiple regimensL [1.4] 27% (37) 1996-2002 1-60 mo P<0.05 Low Continued … Direct comparisons of angioplasty or surgery and medical treatment for renal artery stenosis (continued … Angioplasty with stent placement for treatment of renal artery stenosis (continued) Results HTN (% … Angioplasty with stent placement for treatment of renal artery stenosis (continued) Results HTN (%

19. QR Medica Web Site (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/ebc-challenge-1stplace-qrmedica.pdf
    January 01, 2013 - For Clinicians: Middle Ear Infection: Diagnosis For Clinicians: Middle Ear Infection: Diagnosis (continued … For Clinicians: Middle Ear Infection: Treatment For Clinicians: Middle Ear Infection: Treatment (continued … ) For Clinicians: Middle Ear Infection: Treatment (continued 2) For Patients and Guardians For Patients … and Guardians: Middle Ear Infection For Patients and Guardians: Middle Ear Infection (continued) About

20. Bladder-Cancer-Non-Muscle-Invasive Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/bladder-cancer-non-muscle-invasive_executive.pdf
    October 01, 2015 - (continued) BCG vs. … (continued) MMC vs. … (continued) BCG vs. … (continued) BCG vs. … (continued) BCG vs.